Insider: MCCORMICK FRANK Director - BridgeBio Pharma, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 83,275 | 679,979 | 763,254 |
| Value | $6,091,566.25 | $49,740,463.85 | $55,832,030.10 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 10/29/2025 | DDS | 43,393 | Indirect | COM | $69.24 | $3,004,349.07 | 679,979 |
| 10/29/2025 | DDS | 31,116 | Indirect | COM | $66.20 | $2,059,748.51 | 735,467 |
| 10/29/2025 | DDS | 111,755 | Indirect | COM | $65.48 | $7,317,315.08 | 766,583 |
| 10/29/2025 | DDS | 3,497 | Indirect | COM | $67.52 | $236,129.68 | 731,970 |
| 10/29/2025 | DDS | 8,598 | Indirect | COM | $68.50 | $588,985.35 | 723,372 |
| 10/27/2025 | DDS | 1,641 | Indirect | COM | $65.00 | $106,665.00 | 878,338 |
| 09/05/2025 | DDS | 74,000 | Direct | COM | $53.16 | $3,933,544.00 | 83,275 |
| 06/24/2025 | DDS | 100,000 | Indirect | COM | $44.23 | $4,422,800.00 | 879,979 |
| 12/26/2023 | DDS | 100,000 | Indirect | COM | $42.06 | $4,206,000.00 | 627,689 |
| 11/13/2020 | DDS | 31,632 | Direct | COM | $42.22 | $1,335,534.67 | 1,268,836 |
| 11/13/2020 | DDS | 58,299 | Direct | COM | $42.91 | $2,501,545.96 | 1,210,537 |
| 11/13/2020 | DDS | 10,069 | Direct | COM | $43.57 | $438,688.21 | 1,200,468 |
| 12/30/2019 | DDS | 16,250 | Direct | COM | $35.74 | $580,840.00 | 1,262,426 |
| 12/30/2019 | DDS | 900 | Direct | COM | $36.86 | $33,171.66 | 1,261,526 |
| 12/27/2019 | DDS | 3,500 | Direct | COM | $38.09 | $133,317.10 | 1,310,739 |
| 12/27/2019 | DDS | 25,531 | Direct | COM | $36.37 | $928,588.00 | 1,335,895 |
| 12/27/2019 | DDS | 13,705 | Direct | COM | $39.27 | $538,236.47 | 1,297,034 |
| 12/27/2019 | DDS | 21,656 | Direct | COM | $36.85 | $797,936.98 | 1,314,239 |
| 12/27/2019 | DDS | 883 | Direct | COM | $41.31 | $36,479.56 | 1,279,293 |
| 12/27/2019 | DDS | 100 | Direct | COM | $42.93 | $4,293.00 | 1,278,576 |
| 12/27/2019 | DDS | 617 | Direct | COM | $42.26 | $26,075.78 | 1,278,676 |
| 12/27/2019 | DDS | 16,858 | Direct | COM | $40.13 | $676,440.74 | 1,280,176 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research